Zurex Pharma Obtains $6,000,000 Series C Funding Round

  • Feed Type
  • Date
    8/15/2016
  • Company Name
    Zurex Pharma
  • Mailing Address
    2113 Eagle Drive Middleton, WI 53562 USA
  • Company Description
    Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company’s mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
  • Website
    http://www.zurex-pharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Zurex intends to use the funds to support pivotal Phase III clinical trials of its lead compound and for general corporate and working capital purposes.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy